Back to search results

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

Abroad (travel likely)Recruiting

Conditions

Hepatocellular Carcinoma (HCC) · Cirrhosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Aarhus University Hospital, Aarhus, Central Jutland, Denmark

    Contact: Study coordinator (Morten Hallengreen, MD. and PhD student) · mohall@clin.au.dk · +4560154398
    Contact: Study coordinator (Peter Jepsen, MD, Clinical Professor) · pj@clin.au.dk · +4529314466

  • Regional Hospital Gødstrup, Herning, Central Jutland, Denmark

    Contact: Study coordinator (Maria J Alexandraki, MD) · maria.alex@midt.rm.dk

  • Horsens Regional Hospital, Horsens, Central Jutland, Denmark

    Contact: Study coordinator (Lisbet Grønbæk, MD. PhD) · Lisbet.Groenbaek@auh.rm.dk · +4578426966

  • Randers Regional Hospital, Randers, Central Jutland, Denmark

    Contact: Study coordinator (Asser M Oppfeldt, MD) · asseoppf@rm.dk · +4561681208

  • Silkeborg Regional Hospital, Silkeborg, Central Jutland, Denmark

    Contact: Study coordinator (Charlotte H Holmboe, MD) · CHARHL@rm.dk

  • Viborg Regional Hospital, Viborg, Central Jutland, Denmark

    Contact: Study coordinator (Michael Sørensen, MD. PhD) · michsoer@rm.dk · +4525379750
View source on ClinicalTrials.gov(opens in a new tab)